# Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B

> **NCT00275938** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 120 (—)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** interferon alpha 2b plus ribavirin
- **DRUG:** interferon alpha 2b plus placebo

## Key facts

- **NCT ID:** NCT00275938
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** —
- **Final completion:** 2001-06
- **Target enrollment:** 120 (—)
- **Last updated:** 2006-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00275938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00275938, "Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00275938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*